Skip to content

Archean Chemical Industries Limited (ACI)

Micro Cap

Chemicals stocks · Micro cap · NSE

Archean Chemical Industries Limited is a leading Indian manufacturer and exporter of specialty marine chemicals, primarily Bromine and Industrial Salt. The company is diversifying into high-growth areas like Silicon Carbide (SiC) power devices, energy storage solutions, bromine derivatives, and specialty mud chemicals.

₹479.75
+1.15 · +0.24%
Market cap ₹5,812 Cr
Data qualityFresh enough for analysisQuote updated 19 Oct, 03:31 pm IST
Details
Quote19 Oct, 03:31 pm IST
Base fundamentals14 Oct 2026 · screener
Latest result31 Jul, 02:04 am IST
Score20 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags15 Aug 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · Chemicals P/E 33.1 (n=45)
Technical timing lens

Trend score and candlestick chart

42Neutral

SMA20 -2.3% / mo · MACD + · near 52W low · sector -4.2pp vs Nifty 500 (3M)

Stock trend: 40
Sector RS: 46
Sector 3M: -9.8% vs Nifty 500 -5.6%

Latest mapped FPI equity flow was not positive. View sector evidence

Technical chart

ACID candles · FIT view-20.5%
Latest close ₹479.75 on 2026-10-19
Bar
+0.2%
RSI
51
MACD hist
1.92
52W pos
15%
Visible chart range
Candle interval
2026-10-19O ₹479.00H ₹486.00L ₹473.10C ₹479.75Vol 2.6L sh
₹436.31₹489.61₹542.90₹596.19₹649.4952L₹479.752026-06VolRSIMACD2026-042026-062026-082026-092026-11
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context

Relative performance and chart statistics

Adjusted completed-session prices, rebased to 100

ACINifty ChemicalsNifty 500
-22%-13%-3%+6%20 Jul1 Sept19 Oct19 Oct 2026ACI -15.4%Nifty Chemicals -8.5%Nifty 500 -5.6%
ACI
-15.4%
Nifty 500
-5.6%
Nifty Chemicals
-8.5%
Vs Nifty 500
-9.8 pp
Chart stats
19 Oct 2026
From 52W high
-29.0%
₹676
52W range position
15%
₹446 - ₹676
ATR (14)
3.7%
₹17.7
Volume vs 20D
0.69x
Latest completed session
Avg traded value
₹18 Cr
20-session average
20D price channel
₹451.4 - ₹507.2
30.9% annualized volatility
Research snapshot

What the evidence says now

Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is weak.

Suggested next step
Check latest quarters
Result consistency is weak; verify whether the thesis is improving or deteriorating.
U-Score
Legacy · WATCHLIST
33

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Latest result
Bad
0

Revenue +12.0% · PAT -25.0% YoY

Technical
Neutral
42

Price trend and sector-relative-strength timing.

Valuation
Legacy model
-35.8%

Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.

Trust
Limited evidence
56

Financial-only signal; management claim evidence is not sufficient yet.

Financials

Fundamentals, quarterly history, margins, returns and balance-sheet evidence

Latest result

Quarter ended 30 Jun 2026

Bad · 0/100

PAT -25% YoY · margin compression · Rev +12% YoY · +9% QoQ

Filed 30 Jul 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹327 Cr+12.0%+8.6%
EBITDA₹67 Cr-14.1%+52.3%
Operating margin21.0%-600 bps+600 bps
PAT₹30 Cr-25.0%+150.0%
PAT margin9.2%-453 bps+518 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Fundamentals

Valuation

P/E
60.00
P/B
3.00
EV/EBITDA
19.56
Market Cap
5812.00Cr

Profitability

ROE
5.42%
ROCE
7.41%
ROA
3.60%
Dividend Y
0.53%

Growth (CAGR)

Revenue 5Y
18.00%
EPS 5Y
18.00%
Revenue 3Y
-9.00%
EPS 3Y
-35.00%

Balance Sheet

Debt/Equity
0.25
Interest Coverage
8.77×
Altman Z
6.27
Book Value
157.00

Cash Flow

FCF Yield
—
FCF Positive Y
3/5
OCF
140.00 Cr
EPS TTM
7.85

Shareholding

Promoter Hold
53.43%
Promoter Pledge
0.00%
Momentum 52W
11%

Financial History

Updated 20/10/2026

Revenue

₹ Cr
Latest: 1,081+3.8% vs prev
01441Mar 2020: 608Mar 2022: 1,130Mar 2023: 1,441Mar 2024: 1,330Mar 2025: 1,041Mar 2026: 1,081FY20FY22FY23FY24FY25FY26

Net Profit

₹ Cr
Latest: 105-35.2% vs prev
-36.00383.0Mar 2020: -36.0Mar 2022: 188Mar 2023: 383Mar 2024: 319Mar 2025: 162Mar 2026: 105FY20FY22FY23FY24FY25FY26

Return on Equity

%
Latest: 648+3687.3% vs prev
-13.70648.0Mar 2020: -13.7%Mar 2022: 13.1%Mar 2023: 22.5%Mar 2024: 17.1%Mar 2025: 648%FY20FY22FY23FY24FY25FY26

Technicals

Trend interpretation, Stage 2, relative strength, volume and indicator evidence

Daily technical trend read

Mixed signals

Signals are conflicting — long-term trend down. RSI 51. Wait for confirmation.

  • Price below SMA200 (long-term downtrend) — short-term bounces likely countertrend.
  • SMA20 falling (~2.4% over last month) — short-term momentum negative.
  • RSI(14) at 51 — rising, no extreme reading.
  • MACD above signal, histogram expanding — bullish momentum building.
  • 29% off 52W high · 8% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Nifty 500 leadership

Relative Strength & Trend Stage

27
RS percentile
Stage 4 Downtrend
1M return
+2.7%
3M return
-15.4%
6M return
-18.8%
1Y return
-25.9%
RS 1D
+1
RS 20D
+14
Sector rank
#14
Industry rank
#43
Stage evidence
  • Price is 10.6% below the 30-week proxy.
  • The 50-DMA is below the 30-week proxy and its slope is falling -2.1%.
  • Both 3-month and 6-month returns are negative.
50-DMA
price below
200-DMA
price below
Sector
weakening
Industry
weakening
Relative-strength line vs Nifty 500 (base 100)
262 observations
19 Oct 2026Value 71.35+1.28%
65748392102Sept 25Feb 26Jun 26Oct 2671
RS vs Nifty 50071

Valuation & peers

U-Score 33 · legacy U-Score band WATCHLIST · valuation evidence and comparable companies

33U-SCORE
WATCHLIST

Fundamental score breakdown

U band · WATCHLIST
Valuation1/30
Growth14/25
Quality0/20
Balance Sheet9/15
Cash Flow3/10
Piotroski
8/9 (+5)
Penalties
1
Raw sum
33

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

33/100 · legacy band WATCHLIST

Positive drivers

  • Piotroski is strong at 8/9.
  • Balance sheet contributes 9/15 to the score.
  • Growth contributes 14/25 to the score.

Main drags

  • Fair-value margin of safety is negative at -35.8%.
  • Quality is weaker at 0/20; verify the latest quarterly trend.
  • Valuation is weaker at 1/30; verify the latest quarterly trend.
Sector valuation model

Cyclical valuation: normalized earnings, not just trailing PE

Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.

Cyclical normalized
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
60.0
PB
3.0
EV/EBITDA
19.6
ROE
5.4%
ROCE
7.4%
FCF Yield
—
Debt/Equity
0.3
MoS
-35.8%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 20 Oct 2026
v4.3-runtime-valuation
Final score
33
Previous: 33
Legacy U-Score band
WATCHLIST
Previous: WATCHLIST
Margin of safety
-35.8%
Previous: -35.8%

Score history

12 stored score snapshots. Latest stored move: +0 points.

20 Oct 2026
v4.3-runtime-valuation
33
33
33
33
33
33
33
33
33
33
33
33

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.

Modelled fair value

Graham Number
₹166.52
-188.1% MoS
Growth-justified P/E
45.0
Growth-justified Value
₹353.25
-35.8% MoS
PEG
3.33

Comparable companies

Peers

Business-comparable peers in Chemicals — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.

Compare all ↗
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
BALAMINES
Micro
Balaji Amines Limited
Specialty Chemicals
match 138
25
33.1
8.7%
-598%
OVERVALUED
ALKYLAMINE
Micro
Alkyl Amines Chemicals Limited
Specialty Chemicals
match 131
63
49.5
41.4%
-1%
UNDERVALUED
SWANCORP
Small
SWAN CORP LIMITED
Specialty Chemicals
match 130
33
37.2
-4.5%
+20%
WATCHLIST
GHCL
Micro
GHCL Limited
Specialty Chemicals
match 129
75
7.3
13.2%
+65%
DEEP VALUE
JUBLINGREA
Large
Jubilant Ingrevia Limited
Specialty Chemicals
match 125
51
32.0
9.5%
+28%
FAIR VALUE

Business, management & trust

Growth engines, risks, management commitments and evidence-backed delivery

Business and thesis

Where growth can come from, and what can break the case

Thesis under stressReviewed 2026-06-08T07:07:56.297Z
Management commentary snapshot

FY26 revenue grew 3% YoY to Rs. 11,080 mn, but Q4FY26 revenue declined 13% YoY. Consolidated EBITDA and PAT saw significant YoY declines, impacted by moderation in Industrial Salt, technical downtime in Bromine, and logistics challenges.

The core business performance is mixed, with declining profitability in FY26. While strategic diversification into semiconductors and energy storage is promising, these are early-stage ventures with execution risks and no immediate financial contribution. Logistics issues and technical downtime further pressured results.

Growth engines

Silicon Carbide (SiC) Power Devices

Integrated facility for SiC-based compound semiconductors, first commercial fab in India, 60,000 wafers/year capacity.

Energy Storage Solutions

Investment in Zinc Bromide battery technology, plans for pilot UK facility and India giga-factory.

Bromine Derivatives

Targeting breakeven in FY27, launched new products, with additional products under development.

Specialty Mud Chemicals

Commercial operations commenced at initial scale, customer trials progressing, 5 plants.

Capacity and execution

SiCSem Facility

Annual capacity of 60,000 wafers and packaging capacity of 96 million units.

Bromine Derivatives

Flame Retardant Bromine project expected to come on stream over next 12-18 months.

Specialty Mud Chemicals

Successfully commissioned three plants.

Brine Field Expansion

Undertaken a brine field expansion project within premises to significantly improve overall volumes.

Tailwinds

Strong Industrial Salt Demand

Healthy demand for Industrial Salt, partly negating Q4 logistics challenges.

Semiconductor Mission Support

SiCSem executed Fiscal Support Agreement with India Semiconductor Mission for eligible fiscal support.

Growing Energy Storage Market

Global demand for stationary energy storage expected to exceed $30 billion by 2030.

Increasing Bromine Demand

Driven by various industries, stringent safety standards, and expanding industrial applications.

Headwinds

Geopolitical Disruptions

Impacted exports (78% of revenue) with higher transit time and elevated freight costs.

Logistics Cost Increase

Gujarat government circular on road repairs and rising fuel prices led to a 50% effective impact on per litre fuel cost.

Bromine Production Downtime

Production impacted by technical downtime during the year, though corrective measures are implemented.

Bromine Derivatives Slower Growth

Business grew slower than expected in FY26.

Risk radar

Execution Risk for New Ventures

Semiconductor, Energy Storage, Bromine Derivatives, and Specialty Mud Chemicals are in early stages or facing delays.

Geopolitical & Logistics Disruptions

Ongoing geopolitical issues and domestic logistics challenges could continue to impact export-oriented business and costs.

Customer Concentration

Top 10 customers contributed 87% of FY26 revenue, indicating high reliance on a few clients.

Management accountability

What management said, and what results must prove

Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.

Analyst reading lens
Compare BOTH

YoY comparison is essential for understanding the underlying performance of seasonal businesses like Industrial Salt and for annual trends. QoQ is relevant for assessing sequential momentum, especially for new projects and the recovery from technical downtime in Bromine.

Sector KPIs management disclosed

Total Revenue (Consolidated)

FY26: Rs. 11,080 mn (+3% YoY); Q4FY26: Rs. 3,063 mn (-13% YoY).

EBITDA (Consolidated)

FY26: Rs. 2,657.3 mn (-24.3% YoY); Q4FY26: Rs. 490.8 mn (-48.9% YoY).

PAT (Consolidated)

FY26: Rs. 1,054.1 mn (-35% YoY); Q4FY26: Rs. 122.3 mn (-77.2% YoY).

Industrial Salt Volume

FY26: 4.25 Mn tons (+22.1% YoY); Q4FY26: 1.18 Mn tons (-7.2% YoY).

Management forward view

Bromine Derivatives

Targeting breakeven in FY27, supported by improved capacity utilization.

Sulphate of Potash (SOP)

Meaningful business expected to contribute in H2FY27 after re-engineering product and manufacturing process.

SiCSem Project

Positioned as the first commercial compound fab in the country.

Offgrid Energy Labs

Intention to establish a giga-factory in India in the near future to scale Zinc Bromide battery production.

Thesis monitor

Numbers and claims to verify in the next filings

CheckpointCurrent evidenceWhat to verify next
Bromine Derivatives BreakevenGrew slower than expected in FY26.Achievement of breakeven in FY27 and improved capacity utilization.
SOP Business ContributionRe-engineering product and manufacturing process.Meaningful business contribution in H2FY27.
SiCSem Project ProgressFiscal Support Agreement executed, groundbreaking ceremony in Nov 2025.Construction progress, commissioning timelines, and initial production.
Logistics Cost MitigationOwn fleet trips impacted, working with third-party logistics partners.Effectiveness of mitigation strategies on logistics costs and transit times.

Verification checkpoints are IndiaPulse research interpretation, not investment advice.

Trust Score
56Limited evidence · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Limited evidence: Claim history is still being built. It ranks around the 18th percentile of the scored universe and 11th percentile within Chemicals. Main check: results consistency is weak at 17/100.

This is a financial-behaviour screen, not a claim-tested management reliability verdict.

Computed 05 Sept 2026
management-trust-v1
59 docs text-extracted · 26 concalls text-extracted
Score band
Limited evidence

Financial behaviour is scored, but management claims do not yet have enough outcome checks.

Relative rank
18th percentile

overall median 67 · Chemicals: 11th pctile, median 73 · Micro: 11th pctile, median 73

Evidence depth
Financial-only

59 documents have extracted text, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Limited evidence · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Needs extra due diligence; demand valuation comfort and recent improvement.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
78
strong · holding, pledge, alignment
Cash flow
55
watch · profit to cash conversion
Balance sheet
89
strong · leverage and solvency
Discipline
30
weak · capital discipline
Results
17
weak · quarterly consistency

Trust positives

  • ▸Promoter pledge is zero.

Trust risks

  • ▸3 latest quarters had PAT decline worse than 25% YoY.
  • ▸ROCE is low at 7.4%.
  • ▸ROE is low at 5.4%.
  • ▸ROCE trend is -7.6%.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Important announcements & filings

Latest exchange and company disclosures found within the past two years.

11 shown
Investor presentationAug 2026

Aug 2026 · PPT

Source: Bse

Open source ↗
Concall transcriptAug 2026

Aug 2026 · Transcript

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication 31 Jul

Source: Bse

Open source ↗
AnnouncementJun 2026

Jun 2026 · Announcement under Regulation 30 (LODR)-Change in Management 12 Jun - Shareholders approved auditor reappointment and two independent directors’ reappointment at 17th AGM on June 12, 2026.

Source: Bse

Open source ↗
Investor presentationMay 2026

May 2026 · PPT

Source: Bse

Open source ↗
Concall transcriptMay 2026

May 2026 · Transcript

Source: Bse

Open source ↗
Investor presentationMay 2026

May 2026 · PPT

Source: Bse

Open source ↗
Concall transcriptMay 2026

May 2026 · Transcript

Source: Bse

Open source ↗
AnnouncementMay 2026

May 2026 · Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 25 May - Archean Chemical will attend 360 ONE Capital Trinity India 2026 investor meetings on May 28, 2026.

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Acquisition 30 May - Archean Chemical to invest up to Rs.170 crore in Acume Chemicals rights issue within one month.

Source: Bse

Open source ↗
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.